Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Open in API
Filings indexed 638 across all filing types
Latest filing 2020-05-07 Regulatory Filings
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2020-05-07 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Medexus Pharmaceuticals has obtained public reimbursement approval for a pharmaceutical product (Triamcinolone Hexacetonide Injectable Suspension) in Canada. It discusses the product, its market potential, and includes forward-looking statements. There is no financial data, no detailed financial report, no regulatory filing or certification, no meeting materials, no voting results, no management or board changes, no earnings or interim report, no merger or acquisition information, and no legal proceedings. The document is a corporate announcement about a product reimbursement approval, which fits best under a general regulatory announcement or miscellaneous corporate news. Given the absence of a more specific category, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other categories. The document length (7681 characters) and content confirm it is not a brief report publication announcement or a short notice but a full announcement. Confidence is high due to clear content and context.
2020-04-08 English
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing that Medexus Pharmaceuticals Inc. will present at the 2020 Spring Investor Summit. It includes details about the event, the company's presentation schedule, and contact information for investor relations. There is no financial data, no detailed report, no voting results, no management changes, and no regulatory filings. The document is essentially an announcement of an upcoming investor presentation event, not the presentation itself or a financial report. Therefore, the most appropriate classification is Investor Presentation (IP), as it relates to a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation content is not included here, the announcement is about the presentation event.
2020-03-23 English
News release - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a detailed business update from Medexus Pharmaceuticals regarding its response to the COVID-19 pandemic, including operational impacts, supply chain status, financial strategy, and issuance of common shares to satisfy interest payments on convertible debentures. It discusses ongoing business conditions, financial impacts, and strategic decisions but does not contain formal financial statements or comprehensive financial performance data typical of an annual or interim report. It also does not fit into categories like earnings release, capital update, or management reports as it is more of a general business update and strategic communication. The document is longer than 5,000 characters and contains substantive information, so it is not a mere announcement. Given the nature of the content, it best fits under Capital/Financing Update (CAP) because it includes information about issuing shares to satisfy interest payments on debentures, which is a financing activity, alongside the business update context.
2020-03-23 English
Material change report - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing a metallurgical collaboration between Commerce Resources Corp. and CanmetMINING for test work on the Ashram Deposit. It discusses preliminary test results, ongoing research programs, and upcoming presentations at a conference. There are no financial statements, regulatory filings, or detailed financial data included. The content is primarily an operational update and collaboration announcement rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not a presentation or management discussion. Given the nature of the document as a corporate news release about a technical collaboration and research progress, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other specific categories.
2020-03-09 English
Other.pdf
Merger & Acquisition Classification · 100% confidence The document is titled 'LLC PURCHASE AGREEMENT' and details the terms and conditions of a purchase transaction involving membership interests in a limited liability company. It includes sections on purchase price, closing conditions, deferred payments, and other transaction-related provisions. There is no indication that this is a financial report, regulatory filing, earnings release, or any other type of corporate disclosure report. Instead, it is a legal agreement related to a merger or acquisition transaction. Therefore, the document fits best under the category of Merger & Acquisition filings, which cover merger, acquisition, and tender-offer filings such as purchase agreements.
2020-03-09 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.